Posts

QIAGEN Showcases Sample to Insight Solutions for Complex Oncology at AACR 2026

on
QIAGEN is showcasing its Sample to Insight portfolio at the AACR Annual Meeting 2026 in San Diego, April 17–22, at Booth #3547. The portfolio connects sample preparation, multi-omics profiling, and genomic data interpretation for cancer research and molecular diagnostics. New unveiling: QIAsymphony Connect, a platform for automated clinical sample prep. Events include Spotlight Theater session on April 20, 3–4 p.m. in Theater D on genomic technologies and data science in cancer research. Demonstrations cover QIAseq xHYB Pro for tumor profiling, transrenal DNA methods, multimodal workflows, and AI-driven cancer discovery. Sources:

Roche Launches New Phase 3 Trial for Elevidys to Address EU Rejection in DMD

on

Cochrane Review Finds Anti-Amyloid Alzheimer's Drugs Lack Clinically Meaningful Effect, Sparking Debate

on

OpenAI Debuts Life Sciences AI Model with Retro Biosciences Partnership

on

Novartis CEO Vas Narasimhan Joins Anthropic's Board

on

Xilio Therapeutics Appoints Cheryl R. Blanchard, Ph.D. to its Board of Directors

on

FDA to Review Reclassifying Peptides Following RFK Jr.'s Push Ahead of July Advisory Meeting

on

Novartis CEO Vas Narasimhan Joins Anthropic Board to Advance Responsible AI in Healthcare

on

Terremoto Raises $108M to Make an 'Earthquake' in Small Molecule Space

on

NeuraClick Expands Scientific and Translational Leadership with Key Advisory Appointments

on

Pivotal Pancreatic Cancer Data Fuels Revolution Medicines' Upsized $2B Offering

on

Beeline Biotech Launches with $300M Funding and Bristol Myers Squibb-Derived Pipeline

on

Magnetic Seizure Therapy Shows Efficacy and Safety Comparable to Electroconvulsive Therapy for Depression

on